Beacon Biosignals, Inc.
Last verified 2026-05-07. JSON
| Total raised | $103.0M |
|---|---|
| Latest round | Funding round, $103.0M, 2025-10-07 |
| Founded | unknown |
| Headquarters | BOSTON, MA |
| Industry | other technology |
| Stage | unknown |
| Website | beaconbiosignals.com |
Neurotech platform combining the FDA-cleared Waveband EEG headband with AI analytics that produce quantitative biomarkers of brain function from sleep and wake data. Used by pharma and biotech sponsors running CNS, sleep and neuropsych trials. Pairs clinical-grade home EEG with millions of hours of training data, enabling precision biomarkers, patient stratification and dose-response signals.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-10-07 | Funding round | $103.0M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $103.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $103.0M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | beaconbiosignals.com, read 2026-05-07 |
| Description | self-reported | beaconbiosignals.com, read 2026-05-07 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $103.0M, 2025-10-07 → Funding round, $103.0M, 2025-10-07, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $103.0M, 2025-10-07 → Funding round, $103.0M, 2025-10-07 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes